Moderately elevated plasma homocysteine impairs functional endothelial recovery following denudation of mouse carotid arteries

Metabolism: Clinical and Experimental

Volumn 53, Issue 6, 2004, Pages 760-765

  Miller, Alastair L ^b   Witchel, Harry J ^b   Hancox, Jules C ^b   Jackson, Christopher L ^a   Jeremy, Jamie Y ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; POLITEF;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INJURY; ARTICLE; ATTENUATION; BLOOD LEVEL; CAROTID ARTERY; CELL FUNCTION; CELL GROWTH; CHEMOSENSITIVITY; COMMON CAROTID ARTERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; HETEROZYGOSITY; KNOCKOUT MOUSE; MALE; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ACETYLCHOLINE; ANIMALS; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CYSTATHIONINE BETA-SYNTHASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; RECOVERY OF FUNCTION; VASODILATION; VASODILATOR AGENTS;

EID: 3042813953     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.12.020     Document Type: Article

References (45)

1. McCully K.S. Vascular pathology of homocysteinemia implications for the pathogenesis of arteriosclerosis. Am J Pathol. 56:1969;111-128
2. Boushey C.J., Beresford S.A.A., Omenn G.S., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease Probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057
3. Alfthan G., Pekkanen J., Jauhiainen M., et al. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 106:1994;9-19
4. Evans R.W., Shaten B.J., Hempel J.D., et al. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol. 17:1997;1947-1953
5. Lentz S.R. Homocysteine and vacular dysfunction. Life Sci. 61:1997;1205-1215
6. Dudman N.P.B. An alternative view of homocysteine. Lancet. 354:1999;2072-2074
7. Celermajer D.S., Sorensen K., Ryalls M., et al. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 22:1993;854-858
8. Tawakol A., Omland T., Gerhard M., et al. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 95:1997;1119-1121
9. Woo K.S., Chook P., Lolin Y.I., et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 96:1997;2542-2544
10. Bellamy M.F., McDowell I.F.W., Ramsey M.W., et al. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelial function in healthy adults. Circulation. 98:1998;1848-1852
11. Chambers J.C., McGregor A., Jean-Marie J., et al. Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet. 351:1998;36-37
12. Hanratty C.G., McGrath L.T., McAuley D.F., et al. The effects of oral methionine and homocysteine on endothelial function. Heart. 85:2001;326-330
13. Lentz S.R., Sobey C.G., Piegors D.J., et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest. 98:1996;24-29
14. Quéré I., Hillaire-Buys D., Brunschwig C., et al. Effects of homocysteine on acetylcholine- and adenosine-induced vasodilatation of pancreatic vascular bed in rats. Brit J Pharmacol. 122:1997;351-357
15. Ungvari Z., Pacher P., Rischak K., et al. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 19:1999;1899-1904
16. Eberhardt R.T., Forgione M.A., Cap A., et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest. 106:2000;483-491
17. Lang D., Kredan M.B., Moat S.J., et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta Role for superoxide anions. Arterioscler Thromb Vasc Biol. 20:2000;422-427
18. Wall R.T., Harlan J.M., Harker L.A., et al. Homocysteine-induced endothelial cell injury in vitro A model for the study of vascular injury. Thromb Res. 18:1980;113-121
19. Stamler J.S., Osborne J.A., Jaraki O., et al. Adverse vascular effects of homocysteine are modulated by endothelium- derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318
20. Upchurch G.R. Jr, Welch G.N., Fabian A.J., et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 272:1997;17012-17017
21. Durand P., Prost M., Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis. 121:1996;231-243
22. Ungvari Z., Sarkadi-Nagy E., Bagi Z., et al. Simultaneously increased TxA2 activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 20:2000;1203-1208
23. Berwanger C.S., Jeremy J.Y., Stansby G. Homocysteine and vascular disease. Br J Surg. 82:1995;726-731
24. Stampfer M.J., Malinow M.R., Willett W.C., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881
25. Ridker P.M., Manson J.E., Buring J.E., et al. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 281:1999;1817-1821
26. Emsley A.M., Jeremy J.Y., Gomes G.N., et al. Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br J Pharmacol. 126:1999;1034-1040
27. Watanabe M., Osada J., Aratani Y., et al. Mice deficient in cystathionine beta-synthase Animal models for mild and severe homocyst(e)inemia. Proc Nat Acad Sci USA. 92:1995;1585-1589
28. Lentz S.R., Erger R.A., Dayal S., et al. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol. 279:2000;H970-H975
29. Davies M.J., Woolf N., Rowles P.M., et al. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 60:1988;459-464
30. Jackson C.L. Regrowth of arterial endothelium after denuding injury in the apolipoprotein E knockout mouse. J Vasc Res. 33:1996;42
31. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 41:1977;19-26
32. Miller A.L., Plane F., Jeremy J.Y., et al. Delayed recovery of receptor-mediated functional responses to acetylcholine in mouse isolated carotid arteries following endothelial denudation in vivo. J Vasc Res. 40:2003;449-459
33. Kang S.-S., Wong P.W.K., Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Ann Rev Nutr. 12:1992;279-298
34. Chambers J.C., McGregor A., Jean-Marie J., et al. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia An effect reversible with vitamin C therapy. Circulation. 99:1999;1156-1160
35. Chambers J.C., Obeid O.A., Kooner J.S. Physiological increments in plasma homocysteine induce vascular endothelial dysfunction in normal human subjects. Arterioscler Thromb Vasc Biol. 19:1999;2922-2927
36. Hanratty C.G., McAuley D.F., McGurk C., et al. Homocysteine and endothelial vascular function. Lancet. 351:1998;1288-1289
37. Hanratty C.G., McAuley D.F., McGrath L.T., et al. Hyperhomocysteinaemia in young adults is not associated with impaired endothelial function. Clin Sci. 100:2001;67-72
38. McAuley D.F., Hanratty C.G., McGurk C., et al. Effect of methionine supplementation on endothelial function, plasma homocysteine, and lipid peroxidation. J Toxicol Clin Toxicol. 37:1999;435-440
39. Mudd S.H., Havlik R., Levy H.L., et al. A study of cardiovascular risk in heterozygotes for homocystinuria. Am J Hum Genet. 33:1981;883-893
40. Wilcken D.E.L., Reddy S.G., Gupta V.J. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metabolism. 32:1983;363-370
41. Brattström L., Wilcken D.E.L., Ohrvik J., et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease The result of a meta- analysis. Circulation. 98:1998;2520-2526
42. Chataigneau T., Feletou M., Huang P.L., et al. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol. 126:1999;219-226
43. Harker L.A., Ross R., Slichter S.J., et al. Homocystine-induced arteriosclerosis The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 58:1976;731-741
44. Berman R.S., Martin W. Arterial endothelial barrier dysfunction Actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. Br J Pharmacol. 108:1993;920-926
45. Zhang X., Li H., Jin H., et al. Effects of homocysteine on endothelial nitric oxide production. Am J Physiol. 279:2000;F671-F678